JM
Jagdish Madhavlal Chaudhary
About Jagdish Madhavlal Chaudhary
Data last updated:
Jagdish Madhavlal Chaudhary is a Director at Shankus Hospitals Private Limited (since 2022), Director at Shankus Pharma Private Limited (since 2021) and Director at Keshav Holiday Resort Pvt Ltd (since 2018), and holds 6 more current directorships. The companies operate in Healthcare, Pharma and Travel and Hospitality. The 6 current companies with reported revenue have a combined latest revenue of ₹235 Cr; the largest is Shankus Hospitals Private Limited at ₹114 Cr (FY 2025). Earlier, Jagdish Madhavlal Chaudhary was a Director at Shanku's Biosciences Private Limited (2007–2015) and Director at Shankus Samudaya Hospitals Private Limited (2025–2026) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Apr 2022 | 2022 | ₹114 Cr (FY 2025) | Active | |
| Director | 23 Nov 2021 | 2021 | ₹62.35 Cr (FY 2025) | Active | |
| Director | 15 Jun 2018 | 1992 | ₹55.70 Cr (FY 2025) | Active | |
| Director | 23 Feb 2023 | 2023 | ₹2.66 Cr (FY 2025) | Active | |
| Director | 23 Aug 2023 | 2023 | ₹42.3 Lakh (FY 2025) | Active | |
| Director | 15 Jun 2018 | 1992 | ₹18 Lakh (FY 2025) | Active | |
| Director | 10 Apr 2026 | 2026 | Inactive For E-Filing | ||
| Director | 11 Apr 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Aug 2007 | 2007 | ₹31.50 Cr (FY 2024) | Active | |
| Director | 12 Feb 2025 | 2025 | Active | ||
| Director | 10 Sep 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jagdish Madhavlal Chaudhary
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jagdish Madhavlal Chaudhary
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jagdish Madhavlal Chaudhary
Jagdish Madhavlal Chaudhary currently holds 9 directorships: Shankus Hospitals Private Limited (Director, since 28 Apr 2022, revenue ₹114 Cr (FY 2025)); Shankus Pharma Private Limited (Director, since 23 Nov 2021, revenue ₹62.35 Cr (FY 2025)); Keshav Holiday Resort Pvt Ltd (Director, since 15 Jun 2018, revenue ₹55.70 Cr (FY 2025)); Neovant Therapeutics Private Limited (Director, since 23 Feb 2023, revenue ₹2.66 Cr (FY 2025)); Clinoquent Research Private Limited (Director, since 23 Aug 2023, revenue ₹42.3 Lakh (FY 2025)); and 4 more.
Jagdish Madhavlal Chaudhary was first appointed on 24 Aug 2007 as Director at Shanku's Biosciences Private Limited. The most recent appointment on record is 10 Apr 2026 at Shankus Entertainment Private Limited.
The 6 current companies of Jagdish Madhavlal Chaudhary that report revenue have a combined latest revenue of ₹235 Cr: Shankus Hospitals Private Limited ₹114 Cr (FY 2025); Shankus Pharma Private Limited ₹62.35 Cr (FY 2025); Keshav Holiday Resort Pvt Ltd ₹55.70 Cr (FY 2025); Neovant Therapeutics Private Limited ₹2.66 Cr (FY 2025); Clinoquent Research Private Limited ₹42.3 Lakh (FY 2025); and 1 more.
Jagdish Madhavlal Chaudhary held 3 earlier board appointments: Shanku's Biosciences Private Limited (Director, 24 Aug 2007 to 01 Sep 2015); Shankus Samudaya Hospitals Private Limited (Director, 12 Feb 2025 to 08 Aug 2026); Surya Infraland Private Limited (Director, from 10 Sep 2013).
The current boards of Jagdish Madhavlal Chaudhary's companies include Dilip Shankarbhai Chaudhary (Shankus Hospitals Private Limited), Grishma Pravinkumar Patel (Shankus Hospitals Private Limited), Sandeep Dashrathbhai Prajapati (Shankus Hospitals Private Limited), Nysa Dilip Chaudhary (Shankus Pharma Private Limited), Manojkumar Madhavlal Chaudhari (Keshav Holiday Resort Pvt Ltd), Rakeshkumar Keshavlal Chaudhary (Keshav Holiday Resort Pvt Ltd), among others.